National Drug Control Policy Office 2006 – Federal Register Recent Federal Regulation Documents
Results 1 - 4 of 4
Paperwork Reduction Act; Proposed Collection; Comment Request
The Office of National Drug Control Policy (ONDCP) intends to submit the following information collection request to the Office of Management and Budget for review and approval. ONDCP seeks public comment. Abstract: ONDCP will conduct face-to-face interviews and acquire urine samples from booked arrestees to obtain information concerning drug use; drug and alcohol treatment; and, drug market participation and arrests. The use and manufacture of methamphetamines are of particular interest. Participation is voluntary. Type of Information Collection: New collection. Title: Arrestee Drug Abuse Monitoring (ADAM II) Program Questionnaire. Affected Public: Persons arrested and booked in one of 10 pre- selected booking facilities in the United States in one of two, 2-week data collection cycles spanning six months. Estimated Burden: ADAM II proposes 10 sites that each conduct two cycles of surveys from 250 arrestees per cycle. The total number of participants is 5000. The average survey estimate is 20 minutes. Total burden estimate is 1667 hours. Goals: ONDCP intends to obtain drug-use data that is directly comparable to data collected under the 2000-2003 National Institute of Justice sponsored Arrestee Drug Abuse Monitoring program; provide consistent data collection points to support statistical trend analysis for the use of heroin, cocaine, crack, marijuana and methamphetamine; monitor the spread or emergence of methamphetamine use; and, support ONDCP's efforts to estimate chronic drug use and examine drug market behaviors. Comment Request: Public comments should address whether the proposed data is proper for the functions of the agency; whether the information will have practical utility; the accuracy of ONDCP's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions; the quality, utility, and clarity of the information to be collected; and, the burden on proposed respondents, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, such as electronic submission of responses. Comments will be accepted for sixty days.
Meeting of the Advisory Commission on Drug Free Communities
In accordance with the Drug Free Communities Act, a meeting of the Advisory Commission on Drug Free Communities will be held on December 7 and 8, 2006, at the Office of National Drug Control Policy in the 5th Floor Conference Room, 750 17th Street NW., Washington, DC. The meeting will commence at 8:30 a.m. on Thursday, December 7, 2006 and adjourn for the evening at 5:30 p.m. The meeting will reconvene at 8:30 a.m. on Friday, December 8, 2006 in the same location. The meeting will adjourn at 4 p.m. on Friday, December 8, 2006. The agenda includes: Remarks by ONDCP Director John P. Walters, remarks by ONDCP Deputy Director Mary Ann Solberg, remarks by the DFC Program's Administrator, a discussion of the program's evaluation, a review of new grant awards, and an update from the Substance Abuse and Mental Health Services Administration. There will be an opportunity for public comment from 9-9:30 on Friday December 8, 2006. Members of the public who wish to attend the meeting and/or make public comment should contact Carlos Dublin, at (202) 395-6762 to arrange building access.
Leadership Conference on Medical Education in Substance Abuse, November 30-December 1, 2006
A conference of leaders in the field of medical education in substance abuse will be held on Thursday, November 30 and Friday, December 1, 2006, at the Westin Embassy Row Hotel, Massachusetts Avenue, NW., Washington, DC. The conference will begin at 6 p.m. on Thursday, November 30 and conclude at 5:30 p.m. on Friday, December 1. The specific objectives of the Leadership Conference are: (1) To enhance awareness of the contribution substance abuse screening and brief intervention programs can make to public health in the United States; (2) To identify best practices to cope with emerging patterns of drug- specific abuse; (3) To receive reports on improvements in medical education in drug and alcohol-related disorders; and (4) To encourage the development of medical education curricula on alcohol and other drug related disorders. Members of the public who wish to attend the meeting should telephone ONDCP's Leadership Conference on Medical Education telephone line at (202) 395-6750 to arrange building access.
Appointment of Members of Senior Executive Services Performance Review Board
The following persons have been appointed to the ONDCP Senior Executive Service Performance Review Board: Ms. Michele Marx, Mr. Joseph Keefe, Mr. Robert Denniston, and Mr. Patrick Ward.